Eli Lilly and Company (LLY) — chart, structure and Closelook read

Pick a ticker to load its detail page.

About Eli Lilly and Company

Eli Lilly and Company (LLY) trades on US exchanges, classified under Healthcare. It is a constituent of HALO Growth 100.

The Closelook company score reads 66/100 composite (momentum 70, quality 92, valuation 37) across 7 modules — the full three-layer breakdown, chart structure and analog history load live above.

The print record

9 of 10 EPS beats and 8 of 10 revenue beats across the covered prints, with three-day reactions splitting 4 up · 3 flat · 3 down (as of the 2026-08-03 card). The calmest record in the series — and that is the finding. While the AI names swing ±15 to ±30 on their prints, Eli Lilly's entire ten-print distribution fits inside ±7.4%: nine EPS beats, a 4-3-3 reaction count, nothing violent in either direction. This is what a mega-cap looks like when the market believes the demand story and only argues about pace — the GLP-1 franchise as the anti-AI trade, repricing in single digits while the technology complex reprices in tens. It prints Wednesday morning at 1,125 — 9.9% off its high, above its 200-day — the same morning as Novo Nordisk: a head-to-head print in the one duopoly the tape trusts more than compute.

The full Eli Lilly and Company print-record card →

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: LLY news on the tape · index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-08-07

Quick answers

What is Eli Lilly and Company (LLY)?

Eli Lilly and Company trades as LLY on the US exchange and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-08-07.

Is LLY in a Closelook index?

Yes — Eli Lilly and Company is a constituent of HALO Growth 100, as of 2026-08-07.

What is Eli Lilly and Company's Closelook composite score?

66 out of 100, with momentum 70, quality 92 and valuation 37 sub-scores, as of 2026-08-07. Scores are Closelook's own research readings, not ratings or investment advice.

What is Eli Lilly and Company's earnings print record?

Across the 10 prints Closelook covers, Eli Lilly and Company beat EPS estimates 9 times and revenue estimates 8 times; the three-day reactions split 4 up, 3 flat and 3 down (moves beyond ±3%), as of the 2026-08-03 card. The full print-record card carries the per-print history.

What does this page show?

A live price chart with SMA overlays and drawing tools for LLY, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe